TY  - JOUR
AU  - Gesmundo, Iacopo
AU  - Granato, Giuseppina
AU  - Fuentes-Fayos, Antonio C
AU  - Alvarez, Clara V
AU  - Dieguez, Carlos
AU  - Zatelli, Maria Chiara
AU  - Congiusta, Noemi
AU  - Banfi, Dana
AU  - Prencipe, Nunzia
AU  - Leone, Sheila
AU  - Brunetti, Luigi
AU  - Castaño, Justo P
AU  - Luque, Raul M
AU  - Cai, Renzhi
AU  - Sha, Wei
AU  - Ghigo, Ezio
AU  - Schally, Andrew V
AU  - Granata, Riccarda
PY  - 2021
DO  - 10.3390/cancers13163950
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/18415
T2  - Cancers
AB  - Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal secretion and severe comorbidities. Some patients are resistant to medical therapies; therefore, novel treatment options are needed. Antagonists of growth...
LA  - en
PB  - MDPI
KW  - ACTH-secreting pituitary adenomas
KW  - GH-secreting pituitary adenoma
KW  - GHRH
KW  - Apoptosis
KW  - Cell viability
KW  - Pituitary neoplasms
KW  - Temozolomide
KW  - Cell survival
KW  - Growth hormone-releasing hormone
KW  - Neoplastic processes
KW  - Carcinogenesis
KW  - Cell culture techniques
KW  - Apoptosis
TI  - Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling.
TY  - research article
VL  - 13
ER  -